Eisenmenger’s syndrome screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3]. | |||
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3]. | |||
==Screening== | ==Screening== | ||
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with: | |||
*[Condition 1] | *[Condition 1] | ||
*[Condition 2] | *[Condition 2] |
Revision as of 04:20, 27 January 2020
Eisenmenger’s syndrome Microchapters |
Diagnosis |
---|
Eisenmenger’s syndrome ACC/AHA Guidelines for Evaluation of Patients |
Treatment |
Eisenmenger’s syndrome screening On the Web |
American Roentgen Ray Society Images of Eisenmenger’s syndrome screening |
Risk calculators and risk factors for Eisenmenger’s syndrome screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdelrahman Ibrahim Abushouk, MD[2]
Overview
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
- [Condition 1]
- [Condition 2]
- [Condition 3]